Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial ; day:12 ; month:2 ; year:2021 ; pages:1-8
Cancer immunology immunotherapy ; (12.2.2021), 1-8
- Creator
-
Boye, Kjetil
Longhi, Alessandra
Guren, Tormod
Lorenz, Susanne
Næss, Stine
Pierini, Michela
Taksdal, Ingeborg
Lobmaier, Ingvild
Cesari, Marilena
Paioli, Anna
Løndalen, Ayca M.
Setola, Elisabetta
Hompland, Ivar
Meza-Zepeda, Leonardo A.
Sundby Hall, Kirsten
Palmerini, Emanuela
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-021-02876-w
- URN
-
urn:nbn:de:101:1-2021040314394177410633
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boye, Kjetil
- Longhi, Alessandra
- Guren, Tormod
- Lorenz, Susanne
- Næss, Stine
- Pierini, Michela
- Taksdal, Ingeborg
- Lobmaier, Ingvild
- Cesari, Marilena
- Paioli, Anna
- Løndalen, Ayca M.
- Setola, Elisabetta
- Hompland, Ivar
- Meza-Zepeda, Leonardo A.
- Sundby Hall, Kirsten
- Palmerini, Emanuela
- SpringerLink (Online service)
Other Objects (12)
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Combined exercise and nutrition intervention for older women with spinal sarcopenia: an open-label single-arm trial
Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial
Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer